York E Miller
Northwestern University · University of Colorado, Denver
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name York E Miller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:32 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05411107 · Oral Iloprost for the Prevention of Lung Cancer In Former SmokersNational Cancer Institute (NCI) · withdrawn · Bronchial Epithelial Dysplasia, Chronic Obstructive Pulmonary Disease, Lung Carcinoma · principal investigator
- Ph1NCT02237183 · Iloprost in Preventing Lung Cancer in Former SmokersNational Cancer Institute (NCI) · completed · Lung Carcinoma · principal investigator
- N/ANCT01085864 · Biomarkers for Diagnosis of Lung NodulesUniversity of Colorado, Denver · active not recruiting · Lung Abscess · principal investigator
- N/ANCT00897364 · Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-SmokersUniversity of Colorado, Denver · completed · Lung Cancer, Precancerous Condition · principal investigator
- Ph2NCT00002586 · 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung CancerUniversity of Colorado, Denver · completed · Drug Toxicity, Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- (PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolutionR01CA219893 · NCI · UNIVERSITY OF COLORADO DENVER · fiscal years 2017 to 2022 · $305,715 awarded in 2022Same name and institution; not confirmed by an ID
- Predictors of Lung Nodule MalignancyP50CA058187 · NCI · UNIVERSITY OF COLORADO DENVER · fiscal years 1992 to 2018 · $6,134 awarded in 2018Grant number is on one of their registry trials
- LUNG, HEAD AND NECK CANCERSP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · fiscal years 2001 to 2016 · $36,906 awarded in 2016Same name and institution; not confirmed by an ID
- GASTRIN-RELEASING PEPTIDE RECEPTOR ANALYSIS IN THE LUNGR01HL045745 · NHLBI · UNIVERSITY OF COLORADO DENVER · fiscal years 1991 to 1995 · $197,779 awarded in 1995Same name and institution; not confirmed by an ID
- GENE MAPPING OF CHROMOSOME 3 AND SMALL CELL CARCINOMAR23CA034831 · NCI · UNIVERSITY OF COLORADO DENVER · fiscal years 1985 · $38,174 awarded in 1985Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA060553 · NCI · NORTHWESTERN UNIVERSITY · PI Aleksandar Zafirovski · fiscal years 2012 to 2026Named on NCT05411107, NCT02237183
- Northwestern Cancer Prevention ConsortiumUG1CA242643 · NCI · NORTHWESTERN UNIVERSITY · PI SEEMA Ahsan KHAN · fiscal years 2019 to 2026Named on NCT05411107
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.